7 October 2023
Freshfields advises Novartis on its spin-off of the Sandoz business
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jennifer Bethlehem Lead | Freshfields | Partner | Not stated | Not stated |
| Rikin Morjaria | Freshfields | Counsel | Not stated | Not stated |
| Marc McCaughey | Freshfields | Senior associate | Not stated | Not stated |
| Elisabeth Wulf | Freshfields | Senior associate | Not stated | Not stated |
| Andrew Austin | Freshfields | Partner | Not stated | Not stated |
| David Brooks | Freshfields | Partner | Not stated | Not stated |
| Holly Insley | Freshfields | Partner | Not stated | Not stated |
| Kristen Riemenschneider | Freshfields | Partner | Not stated | Not stated |
| Jon Scurr | Freshfields | Counsel | Not stated | Not stated |
| Harriet Hanks | Freshfields | Counsel | Not stated | Not stated |
7 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Novartis AGSell-side
- Counterparties
- Sandoz (Target)